These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 22137788)
21. Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression. Mizuuchi E; Semba S; Kodama Y; Yokozaki H Int J Cancer; 2009 Apr; 124(8):1802-10. PubMed ID: 19115206 [TBL] [Abstract][Full Text] [Related]
22. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis. Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544 [TBL] [Abstract][Full Text] [Related]
23. PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion. Gari HH; DeGala GD; Ray R; Lucia MS; Lambert JR Cancer Lett; 2016 Oct; 380(2):505-512. PubMed ID: 27452906 [TBL] [Abstract][Full Text] [Related]
24. Emodin, aloe-emodin and rhein induced DNA damage and inhibited DNA repair gene expression in SCC-4 human tongue cancer cells. Chen YY; Chiang SY; Lin JG; Yang JS; Ma YS; Liao CL; Lai TY; Tang NY; Chung JG Anticancer Res; 2010 Mar; 30(3):945-51. PubMed ID: 20393018 [TBL] [Abstract][Full Text] [Related]
25. The essential role of FKBP38 in regulating phosphatase of regenerating liver 3 (PRL-3) protein stability. Choi MS; Min SH; Jung H; Lee JD; Lee TH; Lee HK; Yoo OJ Biochem Biophys Res Commun; 2011 Mar; 406(2):305-9. PubMed ID: 21320469 [TBL] [Abstract][Full Text] [Related]
26. Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis. Yang J; Li H; Chen YY; Wang XJ; Shi GY; Hu QS; Kang XL; Lu Y; Tang XM; Guo QS; Yi J Free Radic Biol Med; 2004 Dec; 37(12):2027-41. PubMed ID: 15544921 [TBL] [Abstract][Full Text] [Related]
27. Emodin and rhein inhibit LIGHT-induced monocytes migration by blocking of ROS production. Heo SK; Yun HJ; Noh EK; Park SD Vascul Pharmacol; 2010; 53(1-2):28-37. PubMed ID: 20298810 [TBL] [Abstract][Full Text] [Related]
28. Antiproliferative and antimetastatic effects of emodin on human pancreatic cancer. Liu A; Chen H; Wei W; Ye S; Liao W; Gong J; Jiang Z; Wang L; Lin S Oncol Rep; 2011 Jul; 26(1):81-9. PubMed ID: 21491088 [TBL] [Abstract][Full Text] [Related]
29. Correlation between reduction potentials and inhibitions of Epstein-Barr virus activation by anthraquinone derivatives. Koyama J; Nisino Y; Morita I; Kobayashi N; Osakai T; Tokuda H Bioorg Med Chem Lett; 2008 Jul; 18(14):4106-9. PubMed ID: 18556196 [TBL] [Abstract][Full Text] [Related]
31. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Zeng Q; Dong JM; Guo K; Li J; Tan HX; Koh V; Pallen CJ; Manser E; Hong W Cancer Res; 2003 Jun; 63(11):2716-22. PubMed ID: 12782572 [TBL] [Abstract][Full Text] [Related]
32. An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells. Wang L; Shen Y; Song R; Sun Y; Xu J; Xu Q Mol Pharmacol; 2009 Dec; 76(6):1238-45. PubMed ID: 19779032 [TBL] [Abstract][Full Text] [Related]
33. Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading. Shin DH; Kim JH; Jung YJ; Kim KE; Jeong JM; Chun YS; Park JW Cancer Lett; 2007 Sep; 255(1):107-16. PubMed ID: 17502124 [TBL] [Abstract][Full Text] [Related]
34. Src-mediated phosphorylation of the tyrosine phosphatase PRL-3 is required for PRL-3 promotion of Rho activation, motility and invasion. Fiordalisi JJ; Dewar BJ; Graves LM; Madigan JP; Cox AD PLoS One; 2013; 8(5):e64309. PubMed ID: 23691193 [TBL] [Abstract][Full Text] [Related]
36. Aloe-emodin-induced apoptosis in human gastric carcinoma cells. Chen SH; Lin KY; Chang CC; Fang CL; Lin CP Food Chem Toxicol; 2007 Nov; 45(11):2296-303. PubMed ID: 17637488 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma. Zhao WB; Li Y; Liu X; Zhang LY; Wang X Int J Mol Med; 2008 Aug; 22(2):187-92. PubMed ID: 18636172 [TBL] [Abstract][Full Text] [Related]
38. Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells. Lai JM; Chang JT; Wen CL; Hsu SL Eur J Pharmacol; 2009 Nov; 623(1-3):1-9. PubMed ID: 19744477 [TBL] [Abstract][Full Text] [Related]
39. Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3. Forte E; Orsatti L; Talamo F; Barbato G; De Francesco R; Tomei L Biochim Biophys Acta; 2008 Feb; 1783(2):334-44. PubMed ID: 18078820 [TBL] [Abstract][Full Text] [Related]
40. Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner. Xu H; Lai W; Zhang Y; Liu L; Luo X; Zeng Y; Wu H; Lan Q; Chu Z BMC Cancer; 2014 May; 14():330. PubMed ID: 24885636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]